Ketamine ameliorates post-traumatic social avoidance by erasing the traumatic memory encoded in VTA-innervated BLA engram cells

Neuron. 2024 Sep 25;112(18):3192-3210.e6. doi: 10.1016/j.neuron.2024.06.026. Epub 2024 Jul 19.

Abstract

Erasing traumatic memory during memory reconsolidation is a promising retrieval-extinction strategy for post-traumatic stress disorder (PTSD). Here, we developed an acute social defeat stress (SDS) mouse model with short-term and re-exposure-evoked long-term social avoidance. SDS-associated traumatic memories were identified to be stored in basolateral amygdala (BLA) engram cells. A single intraperitoneal administration of subanesthetic-dose ketamine within, but not beyond, the re-exposure time window significantly alleviates SDS-induced social avoidance, which reduces the activity and quantity of reactivated BLA engram cells. Furthermore, activation or inhibition of dopaminergic projections from the ventral tegmental area to the BLA effectively mimics or blocks the therapeutic effect of re-exposure with ketamine and is dopamine D2 receptor dependent. Single-cell RNA sequencing reveals that re-exposure with ketamine triggered significant changes in memory-related pathways in the BLA. Together, our research advances the understanding of how ketamine mitigates PTSD symptoms and offers promising avenues for developing more effective treatments for trauma-related disorders.

Keywords: basolateral amygdala; dopamine D2 receptor; ketamine; memory engram cells; post-traumatic stress disorder.

MeSH terms

  • Animals
  • Avoidance Learning* / drug effects
  • Avoidance Learning* / physiology
  • Basolateral Nuclear Complex* / drug effects
  • Basolateral Nuclear Complex* / metabolism
  • Disease Models, Animal
  • Ketamine* / administration & dosage
  • Ketamine* / pharmacology
  • Male
  • Memory / drug effects
  • Memory Consolidation / drug effects
  • Mice
  • Mice, Inbred C57BL*
  • Receptors, Dopamine D2 / metabolism
  • Social Defeat
  • Stress Disorders, Post-Traumatic* / drug therapy
  • Stress Disorders, Post-Traumatic* / metabolism
  • Ventral Tegmental Area* / drug effects

Substances

  • Ketamine
  • Receptors, Dopamine D2